Evidence map›Paper›PMID 30867558›Full record

ReviewMolecular psychiatry2019

Resilience as a translational endpoint in the treatment of PTSD.

Gopalkumar Rakesh, Rajendra A Morey, Anthony S Zannas, Zainab Malik, Christine E Marx, Ashley N Clausen, Michael D Kritzer, Steven T Szabo

Abstract readReview
In one paragraph

Review in Molecular psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Gopalkumar RakeshDuke-UNC Brain Imaging and Analysis Center (BIAC), Durham, NC, 27710, USA. Gopalkumar.rakesh@duke.edu.ORCID http://orcid.org/0000-0002-7134-2804
Rajendra A MoreyDuke-UNC Brain Imaging and Analysis Center (BIAC), Durham, NC, 27710, USA.
Anthony S ZannasDepartments of Psychiatry and Genetics, University of North Carolina, Chapel Hill, NC, 27514, USA.
Zainab MalikChild and Adolescent Psychiatry, University of California, Davis, CA, 95616, USA.
Christine E MarxDurham VA Health Care System, Durham, NC, 27705, USA.
Ashley N ClausenDuke-UNC Brain Imaging and Analysis Center (BIAC), Durham, NC, 27710, USA.
Michael D KritzerDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, 27710, USA.
Steven T SzaboDurham VA Health Care System, Durham, NC, 27705, USA.
Duke University · USAmerican Academy of Child and Adolescent Psychiatry · USMental Illness Research, Education and Clinical Centers · USUniversity of North Carolina at Chapel Hill · US

Funding

Trauma and Genomics Modulate Brain Structure across Common Psychiatric DisordersR01MH111671 · NIMH · DUKE UNIVERSITY · PI MARK W LOGUE, RAJENDRA A MOREY · 2017 to 2026
$4.4M
White Matter Damage in Subconcussive Blast ExposureR01NS086885 · NINDS · DUKE UNIVERSITY · PI MOREY, RAJENDRA A · 2014 to 2018
$1.7M
Brain Systems for Fear Generalization and Threat Processing in PTSDI01CX000748 · VA · DURHAM VA MEDICAL CENTER · PI MOREY, RAJENDRA A · 2014 to 2017
–
Biomarker Candidates in Gulf War Veterans: A 10-year Follow-up InvestigationI01CX001569 · VA · DURHAM VA MEDICAL CENTER · PI MARX, CHRISTINE E. · 2018 to 2024
–
Neurosteroids in PTSD - Biomarkers to TherapeuticsIK2CX001397 · VA · DURHAM VA MEDICAL CENTER · PI SZABO, STEVEN · 2018 to 2021
–
CSRD VA I01 CX000748CSRD VA I01 CX001569CSRD VA IK2 CX001397NIMH NIH HHS R01 MH111671NINDS NIH HHS R01 NS086885
6 · The paper itself

Abstract

Resilience is a neurobiological entity that shapes an individual's response to trauma. Resilience has been implicated as the principal mediator in the development of mental illness following exposure to trauma. Although animal models have traditionally defined resilience as molecular and behavioral changes in stress responsive circuits following trauma, this concept needs to be further clarified for both research and clinical use. Here, we analyze the construct of resilience from a translational perspective and review optimal measurement methods and models. We also seek to distinguish between resilience, stress vulnerability, and posttraumatic growth. We propose that resilience can be quantified as a multifactorial determinant of physiological parameters, epigenetic modulators, and neurobiological candidate markers. This multifactorial definition can determine PTSD risk before and after trauma exposure. From this perspective, we propose the use of an 'R Factor' analogous to Spearman's g factor for intelligence to denote these multifactorial determinants. In addition, we also propose a novel concept called 'resilience reserve', analogous to Stern's cognitive reserve, to summarize the sum total of physiological processes that protect and compensate for the effect of trauma. We propose the development and application of challenge tasks to measure 'resilience reserve' and guide the assessment and monitoring of 'R Factor' as a biomarker for PTSD.

Indexed as

AnimalsBiomarkersHumansNeurobiologyResilience, PsychologicalStress Disorders, Post-TraumaticStress, PsychologicalTreatment OutcomeBiomarkers

Identifiers

PMID30867558
PMCPMC6713904
OpenAlexW2921576925

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.